IMM-101

IMM-101 is a drug that is being studied to see if it is useful in chemotherapy.^[1] It is made from the heat-treated bacterium Mycobacterium obuense. It may have relatively few side effects compared to other drugs.^[2]^[3]

References

^ Dalgleish, AG; Stebbing, J; Adamson, DJ; Arif, SS; Bidoli, P; Chang, D; Cheeseman, S; Diaz-Beveridge, R; Fernandez-Martos, C; Glynne-Jones, R; Granetto, C; Massuti, B; McAdam, K; McDermott, R; Martín, AJ; Papamichael, D; Pazo-Cid, R; Vieitez, JM; Zaniboni, A; Carroll, KJ; Wagle, S; Gaya, A; Mudan, SS (6 September 2016). "Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer". British journal of cancer. doi:10.1038/bjc.2016.271. PMID 27599039.
^ "New drug 'wakes up' immune system to fight one of deadliest cancers".
^ "A trial looking at a new type of immunotherapy for cancer of the pancreas that can't be removed with surgery".

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] Dalgleish, AG; Stebbing, J; Adamson, DJ; Arif, SS; Bidoli, P; Chang, D; Cheeseman, S; Diaz-Beveridge, R; Fernandez-Martos, C; Glynne-Jones, R; Granetto, C; Massuti, B; McAdam, K; McDermott, R; Martín, AJ; Papamichael, D; Pazo-Cid, R; Vieitez, JM; Zaniboni, A; Carroll, KJ; Wagle, S; Gaya, A; Mudan, SS (6 September 2016). "Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer". British journal of cancer. doi:10.1038/bjc.2016.271. PMID 27599039.

[2] "New drug 'wakes up' immune system to fight one of deadliest cancers".

[3] "A trial looking at a new type of immunotherapy for cancer of the pancreas that can't be removed with surgery".

[1]

[2]

[3]